Top compounds associated with response to HOMER2


Feature Type Standardized
Nominal ANOVA
mRNA thalidomide CTRPv2 pan-cancer AAC -0.045 0.4
mRNA Irinotecan gCSI pan-cancer AAC -0.046 0.4
mRNA BMS-536924 GDSC1000 pan-cancer AAC 0.026 0.4
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA azacitidine CTRPv2 pan-cancer AAC -0.03 0.4
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA lapatinib gCSI pan-cancer AAC -0.046 0.4
mRNA VX-680 GDSC1000 pan-cancer AAC -0.044 0.4
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
Download CSV